Recursion Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Recursion Pharmaceuticals

27/02/2024 23:36

* Recursion Pharmaceuticals Inc  RXRX.OQ  reported a
quarterly
adjusted loss of 42 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -31 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 45 cents per
share. Wall Street expected results to range from -59 cents
to -30 cents per share.
    * Revenue fell 20.4% to $10.89 million from a year ago;
analysts
expected $20.35 million. 
    * Recursion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 42 cents​.
    * The company reported a quarterly loss of $93 million.
    * Recursion Pharmaceuticals Inc shares had risen by 49.7%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Recursion
Pharmaceuticals Inc is $12.50 

This summary was machine generated from LSEG data February 27 at
11:35 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.45          -0.42          Beat
 Sep. 30 2023      -0.38          -0.43          Missed
 Jun. 30 2023      -0.37          -0.38          Missed
 Mar. 31 2023      -0.35          -0.34          Beat